Ang II has been demonstrated to significantly increase SBP, left ventricular hypertrophy, and dysfunction, which are established clinical risk factors for AF (Purohit et al., 2013; Jansen et al., 2018). The gene discussed is AGT; the disease is atrial fibrillation.